Information concerning the distribution of various subdomains of the amyloid precursor protein (APP) in brain may illuminate aspects of the normal metabolism of this membrane-associated protein, as well as putative abnormal processing that may occur in Alzheimer disease (AD). We prepared affinity-purified antibody, P2, against an extracytoplasmic APP site and applied it, along with monoclonal antibodies to the j3-peptide, or A4 region, in conjunction with selective cytochemical staining methods, to control and AD tissues. The following was noted: (i) in contrast to A4 epitopes, which are easily demonstrable primarily in extracellular senile plaques of AD patients, the extracytoplasmic P2 antigen was found in association with neurons, glia, and blood vessels in both normal and AD prefrontal cortex; (i) a subset of senile plaques contained both A4 and P2 antigens; (iU) in some instances, P2 antigen occurred as an extracellular deposit in the absence of A4; (iv) the P2 antigen, but not A4, was also associated with corpora amylacea. In addition to identifying the unique cellular distribution of the APP extracytoplasmic antigen, the results support the view that a segment of this domain undergoes processing and deposition at extracellular sites, including a subset of senile plaques.The structure of Alzheimer amyloid precursor protein (APP) cDNA has been determined (1-5) and shown to correspond to a protein of 695 amino acids that has features in common with glycosylated cell-surface receptors (1). Of the APP domains, the A4 (or P-peptide) region consisting of -42 amino acids appears to extend from the extracytoplasmic domain to the transmembrane site (1). Immunologic and biochemical data have firmly established that in the Alzheimer disease (AD) brain the A4 polypeptide is a major component of cerebrovascular and senile plaque amyloid (6)(7)(8)(9)(10)(11). However, no detailed information has been available concerning the cellular or extracellular localization of the extracytoplasmic domain (ECD) of the APP and its distribution with regard to A4 and senile plaques.The present report addresses the issue oflocalization ofthe ECD by means of an affinity-purified antibody, P2, raised to a unique peptide within the extracytoplasmic region of the APP. Both control and AD brains were stained with P2, anti-A4 monoclonal antibodies (mAbs) (10), and anti-glial fibrillary acidic protein, in addition to selective cytochemical counterstains. We report here that an extracytoplasmic APP domain has unique features in both control and AD brains that distinguish it from A4. We report, further, that certain senile plaques of the AD brain contain the extracytoplasmic P2 antigen in addition to the A4 domain and that the P2 antigen alone can accumulate extracellularly.A portion of these data were reported previously in preliminary form (12). (1) was prepared by methods previously described (10). The polypeptide was determined to have a unique sequence as indicated by searches facilitated by BIONET (IntelliGenetics) data bases....